Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Gritstone Oncology Inc (GRTS)
NASDAQ:GRTS
Gritstone Oncology (GRTS) Stock Price & Analysis
460 Followers
GRTS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.64 - $5.85
Previous Close$1.93
Volume577.50K
Average Volume (3M)623.32K
Market Cap
$166.77M
Enterprise Value$61.83M
Total Cash (Recent Filing)$147.88M
Total Debt (Recent Filing)$48.78M
Price to Earnings (P/E)-1.4
Beta1.52
Next Earnings
Aug 03, 2023EPS Estimate
-$0.35Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.34
Shares Outstanding88,913,562
10 Day Avg. Volume918,518
30 Day Avg. Volume623,316
Standard Deviation0.54
R-Squared0.00305
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)1787.53
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.24
Enterprise Value/Gross Profit3.10
Enterprise Value/Ebitda-0.48
Forecast
1Y Price Target
$9.60Price Target Upside380.00% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Gritstone Oncology News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GRTS FAQ
What was Gritstone Oncology Inc’s price range in the past 12 months?
Gritstone Oncology Inc lowest stock price was $1.64 and its highest was $5.85 in the past 12 months.
What is Gritstone Oncology Inc’s market cap?
Currently, no data Available
When is Gritstone Oncology Inc’s upcoming earnings report date?
Gritstone Oncology Inc’s upcoming earnings report date is Aug 03, 2023 which is in 63 days.
How were Gritstone Oncology Inc’s earnings last quarter?
Gritstone Oncology Inc released its earnings results on May 11, 2023. The company reported -$0.3 earnings per share for the quarter, beating the consensus estimate of -$0.345 by $0.045.
Is Gritstone Oncology Inc overvalued?
According to Wall Street analysts Gritstone Oncology Inc’s price is currently Undervalued.
Does Gritstone Oncology Inc pay dividends?
Gritstone Oncology Inc does not currently pay dividends.
What is Gritstone Oncology Inc’s EPS estimate?
Gritstone Oncology Inc’s EPS estimate is -$0.35.
How many shares outstanding does Gritstone Oncology Inc have?
Gritstone Oncology Inc has 88,913,560 shares outstanding.
What happened to Gritstone Oncology Inc’s price movement after its last earnings report?
Gritstone Oncology Inc reported an EPS of -$0.3 in its last earnings report, beating expectations of -$0.345. Following the earnings report the stock price went down -9.962%.
Which hedge fund is a major shareholder of Gritstone Oncology Inc?
Among the largest hedge funds holding Gritstone Oncology Inc’s share is Versant Venture Management, LLC. It holds Gritstone Oncology Inc’s shares valued at 10M.
---
Gritstone Oncology Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$9.60 (380.00% Upside)
$9.60 (380.00% Upside)
Blogger Sentiment
Bullish
GRTS Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 32.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $22.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 4.8%
Last 30 Days ▲ 4.8%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-4.45%
12-Months-Change
Fundamentals
Return on Equity
-75.59%
Trailing 12-Months
Asset Growth
-13.77%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Gritstone Oncology Inc
Gritstone Oncology, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded in August 2015 by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria and is headquartered in Emeryville, CA.
---
Top 5 ETFs holding GRTS
Vanguard Total Stock Market ETF
$5.92M
iShares Biotechnology ETF
$1.02M
iShares Core S&P Total U.S. Stock Market ETF
$150.56K
iShares NASDAQ US Biotechnology UCITS ETF
$73.94K
Dimensional US Core Equity Market ETF
$5.36K
Up to five ETFs with an Outperform Smart Score that hold GRTS. The ETFs are listed according to market value of GRTS within the ETF
---
---